Greenland Mines Ltd (GRML): Total Assets
$9.59M
As of 2025-12-31
$65.01M
As of 2026-06-30
-56.7%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.59M | +290.4% | 2026-08-14, Balance as of period end |
| 2024-12-31 | $2.46M | +12.1% | 2026-08-14, Balance as of period end |
| 2023-12-31 | $2.19M | -98.1% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $118.25M | n/m | 2024-04-17, Balance as of period end |
| 2021-12-31 | $5.0K | n/a | 2023-10-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | 2025-12-31 | $9.59M | +290.4% |
| Dyadic International Inc (DYAI) | 2025-12-31 | $9.95M | +0.2% |
| Calidi Biotherapeutics, Inc. (CLDI) | 2025-12-31 | $8.86M | -37.5% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $11.63M | -13.5% |
| Creative Medical Technology Holdings, Inc. (CELZ) | 2025-12-31 | $7.81M | +17.1% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $7.39M | -49.6% |
| Silexion Therapeutics Corp (SLXN) | 2025-12-31 | $7.21M | +152.0% |
| BioAtla, Inc. (BCAB) | 2025-12-31 | $13.83M | -73.6% |
| Intensity Therapeutics, Inc. (INTS) | 2025-12-31 | $14.10M | +194.8% |
Compare GRML, DYAI, CLDI, SCNI side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗